Literature DB >> 887933

Relaxin: a disulfide homolog of insulin.

C Schwabe, J K McDonald.   

Abstract

Relaxin, a peptide hormone responsible for the widening of the birth canal in mammals, has been purified from the ovaries of pregnant hogs. The amino acid sequences of its constituent A and B chains were determined, and the positions of the disulfide cross-links were established. Relaxin was shown to be identical to insulin with respect to its disulfide bond distribution, but significant homology was lacking in other positions. These findings suggest that relaxin and insulin were derived from a common ancestral gene. Since the intrauterine mode of propagation is synonymous with the development of mammals, the genetic distance between insulin and relaxin should therefore permit an estimate of the earliest possible time of commitment of one evolutionary branch to the development of mammals. This event was estimated to have occurred about 5 X 10(8) years ago.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 887933     DOI: 10.1126/science.887933

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  11 in total

1.  Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family.

Authors:  S B Pierce; M Costa; R Wisotzkey; S Devadhar; S A Homburger; A R Buchman; K C Ferguson; J Heller; D M Platt; A A Pasquinelli; L X Liu; S K Doberstein; G Ruvkun
Journal:  Genes Dev       Date:  2001-03-15       Impact factor: 11.361

2.  The minimal active structure of human relaxin-2.

Authors:  Mohammed Akhter Hossain; K Johan Rosengren; Chrishan S Samuel; Fazel Shabanpoor; Linda J Chan; Ross A D Bathgate; John D Wade
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

Review 3.  Relaxin family peptides: structure-activity relationship studies.

Authors:  Nitin A Patil; K Johan Rosengren; Frances Separovic; John D Wade; Ross A D Bathgate; Mohammed Akhter Hossain
Journal:  Br J Pharmacol       Date:  2017-01-19       Impact factor: 8.739

4.  Chemical heterogeneity as a result of hydroxylamine cleavage of a fusion protein of human insulin-like growth factor I.

Authors:  E Canova-Davis; M Eng; V Mukku; D H Reifsnyder; C V Olson; V T Ling
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

Review 5.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

6.  Solution structure of a conformationally restricted fully active derivative of the human relaxin-like factor.

Authors:  Erika E Büllesbach; Mathias A S Hass; Malene R Jensen; D Flemming Hansen; Søren M Kristensen; Christian Schwabe; Jens J Led
Journal:  Biochemistry       Date:  2008-12-16       Impact factor: 3.162

7.  Structure of the R3/I5 chimeric relaxin peptide, a selective GPCR135 and GPCR142 agonist.

Authors:  Linda M Haugaard-Jönsson; Mohammed Akhter Hossain; Norelle L Daly; Ross A D Bathgate; John D Wade; David J Craik; K Johan Rosengren
Journal:  J Biol Chem       Date:  2008-06-24       Impact factor: 5.157

8.  Effects of relaxin on the mouse mammary gland. III. The fat pad.

Authors:  S Bianchi; G Bani; M Bigazzi
Journal:  J Endocrinol Invest       Date:  1986-04       Impact factor: 4.256

9.  Primate relaxin: synthesis of gorilla and rhesus monkey relaxins.

Authors:  J D Wade; S S Layden; P F Lambert; H Kakouris; G W Tregear
Journal:  J Protein Chem       Date:  1994-04

10.  Relaxin induces matrix-metalloproteinases-9 and -13 via RXFP1: induction of MMP-9 involves the PI3K, ERK, Akt and PKC-ζ pathways.

Authors:  Nisar Ahmad; Wei Wang; Remi Nair; Sunil Kapila
Journal:  Mol Cell Endocrinol       Date:  2012-07-24       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.